• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Heron Therapeutics Shares Are Trading Lower By 34%? Here Are Other Stocks Moving In Friday's Mid-Day Session

    5/12/23 1:09:06 PM ET
    $AIRS
    $AKU
    $ARLO
    $ARRY
    Medical/Nursing Services
    Health Care
    Medical Specialities
    Health Care
    Get the next $AIRS alert in real time by email

    Gainers

    • GSI Technology, Inc. (NASDAQ:GSIT) shares surged 108% to $3.4207. GSI Technology is expected to announce financial results for its fiscal fourth quarter after the market close on May 16, 2023.
    • ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) shares jumped 82.8% to $8.27 after the company reported the FDA's Advisory Committee voted in support of favorable benefit-risk assessment for neffy in the treatment of severe allergic reactions (Type 1), including anaphylaxis.
    • Getaround, Inc. (NYSE:GETR) shares climbed 73.6% to $0.5749 after the company announced it is acquiring substantially all of the assets of HyreCar for an aggregate purchase price of $9.45 million.
    • Dermata Therapeutics, Inc. (NASDAQ:DRMA) shares climbed 45.1% to $2.80 after the company highlighted recent corporate progress, and reported financial results for the first quarter.
    • Jupiter Wellness Acquisition Corp. (NASDAQ:JWAC) surged 40% to $7.10.
    • Blue Bird Corporation (NASDAQ:BLBD) gained 38.7% to $26.80 after the company reported better-than-expected Q2 results.
    • AirSculpt Technologies, Inc. (NASDAQ:AIRS) shares climbed 32.8% to $6.50 after the company reported better-than-expected Q1 financial results.
    • Arlo Technologies, Inc. (NASDAQ:ARLO) gained 24.3% to $8.76 following strong quarterly results.
    • Greenbrook TMS Inc. (NASDAQ:GBNH) rose 23.2% to $0.77.
    • First Solar, Inc. (NASDAQ:FSLR) surged 21.9% to $223.36 after the company announced the acquisition of Evolar.
    • Ouster, Inc. (NYSE:OUST) gained 19.3% to $4.58 following strong Q1 sales results.
    • VYNE Therapeutics Inc. (NASDAQ:VYNE) gained 19.3% to $7.28 after the company reported Q1 financial results.
    • Array Technologies, Inc. (NASDAQ:ARRY) jumped 18.6% to $22.47 following strong quarterly results.
    • SurgePays, Inc. (NASDAQ:SURG) gained 14.7% to $5.06 after the company reported Q1 financial results.
    • Pharming Group N.V. (NASDAQ:PHAR) rose 14.5% to $11.69. Pharming recently posted a Q1 loss of $0.02 per share.
    • P3 Health Partners Inc. (NASDAQ:PIII) jumped 14.3% to $2.64. P3 Health Partners recently posted upbeat quarterly results.
    • Holley Inc. (NYSE:HLLY) gained 12.8% to $3.07. Telsey Advisory Group and Raymond James raised their price targets on the stock.
    • Cidara Therapeutics, Inc. (NASDAQ:CDTX) rose 9.3% to $1.29 following better-than-expected quarterly sales.
    • Hallmark Financial Services, Inc. (NASDAQ:HALL) gained 9.1% to $4.31.
    • News Corporation (NASDAQ:NWS) surged 6.7% to $17.97 following Q3 results.

    Losers

    • Assure Holdings Corp. (NASDAQ:IONM) fell 37.8% to $1.20 after the company announced pricing of a $6 million underwritten public offering.
    • Heron Therapeutics, Inc. (NASDAQ:HRTX) dropped 33.9% to $1.4750 after the company reported mixed Q1 financial results.
    • TOP Financial Group Limited (NASDAQ:TOP) shares fell 29.7% to $6.42 after the SEC said it is temporarily suspending trading in the securities of the company because of "recent, unusual, and unexplained market activity" raising concerns regarding the adequacy and accuracy of publicly-available information.
    • AVITA Medical, Inc. (NASDAQ:RCEL) dropped 24.3% to $11.89 after the company reported mixed Q1 financial results.
    • Freight Technologies, Inc. (NASDAQ:FRGT) declined 23% to $1.54 after the company reported preliminary Q1 2023 revenue of $3.3 million, down from $5.3 million for Q1 prior year 2022.
    • Intrusion Inc. (NASDAQ:INTZ) dropped 22.9% to $1.31 following weak quarterly results.
    • BitNile Metaverse, Inc. (NASDAQ:BNMV) fell 22.3% to $0.0449 after the company announced a 1-for-30 reverse stock split.
    • Audacy, Inc. (NYSE:AUD) dropped 20.6% to $0.1086. Audacy recently reported mixed Q1 financial results.
    • Impel Pharmaceuticals Inc. (NASDAQ:IMPL) fell 19.7% to $1.83 after the company reported a decrease in year-over-year Q1 EPS results and worse-than-expected Q1 sales results.
    • Check-Cap Ltd. (NASDAQ:CHEK) dropped 19% to $1.49 following a wider-than-expected quarterly loss.
    • Dingdong (Cayman) Limited (NYSE:DDL) fell 18.7% to $3.2820 after the company reported worse-than-expected Q1 sales results.
    • Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA) fell 18.5% to $6.74.
    • Akumin Inc. (NASDAQ:AKU) dipped 18.4% to $0.4260. Akumin recently posted a wider quarterly loss.
    • ImmunityBio, Inc. (NASDAQ:IBRX) dropped 18% to $2.2850 after Piper Sandler downgraded the stock from Overweight to Neutral and lowered its price target from $10 to $4.
    • Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA) dipped 17% to $6.86.
    • Cemtrex, Inc. (NASDAQ:CETX) fell 16.5% to $9.10 after the company reported Q2 results.
    • Harrow Health, Inc. (NASDAQ:HROW) dropped 16.3% to $22.66 after the company reported Q1 financial results.
    • VCI Global Limited (NASDAQ:VCIG) fell 14.8% to $3.00 after gaining over 8% on Thursday. VCI Global announced application for dual listing on upstream.
    • Youdao, Inc. (NYSE:DAO) dropped 14.4% to $5.42.
    • OraSure Technologies, Inc. (NASDAQ:OSUR) fell 13.8% to $6.37. OraSure Technologies recently posted upbeat quarterly results.
    • Emergent BioSolutions Inc. (NYSE:EBS) dropped 12.5% to $9.19. Emergent BioSolutions recently reported better-than-expected Q1 sales results.
    • Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) declined 10.6% to $8.27. Marinus Pharmaceuticals reported Q1 financial results.
    • IonQ, Inc. (NYSE:IONQ) shares fell 9.8% to $6.32 after the quantum computing company reported first-quarter financial results.
    • Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM) shares dropped 9.7% to $0.7210. A 13D filing recently showed Baker Bros. Advisors reported a 19.99% active stake in the company.
    • Definitive Healthcare Corp. (NASDAQ:DH) dropped 9% to $8.89.
    • MMTec, Inc. (NASDAQ:MTC) fell 8.2% to $1.01 after gaining more than 5% on Thursday.
    • Unique Fabricating, Inc. (NASDAQ:UFAB) fell 7.4% to $0.2453 after dropping 16% on Thursday.
    • IHS Holding Limited (NYSE:IHS) dropped 7.3% to $8.40.
    • BIOLASE, Inc. (NASDAQ:BIOL) shares dropped 6.8% to $0.2236 after the company posted Q1 results.

     

    Now Read This: Bitcoin Tumbles Below This Key Level Following Economic Data; Pepe, Huobi Token Among Top Losers

    Get the next $AIRS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AIRS
    $AKU
    $ARLO
    $ARRY

    CompanyDatePrice TargetRatingAnalyst
    ImmunityBio Inc.
    $IBRX
    3/12/2026$13.00Buy
    BTIG Research
    Avita Medical Inc.
    $RCEL
    3/5/2026$10.00Outperform
    Northland Capital
    First Solar Inc.
    $FSLR
    2/26/2026$245.00Buy → Hold
    Deutsche Bank
    Array Technologies Inc.
    $ARRY
    2/26/2026$9.00Buy → Hold
    Deutsche Bank
    First Solar Inc.
    $FSLR
    2/25/2026$211.00Buy → Hold
    HSBC Securities
    First Solar Inc.
    $FSLR
    2/25/2026$205.00Outperform → Neutral
    Robert W. Baird
    Array Technologies Inc.
    $ARRY
    2/25/2026$19.00Neutral → Outperform
    BNP Paribas Exane
    First Solar Inc.
    $FSLR
    2/25/2026$320.00 → $253.00Buy
    TD Cowen
    More analyst ratings

    $AIRS
    $AKU
    $ARLO
    $ARRY
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Verde Clean Fuels, Inc. Announces New CEO and Engagement of Financial Advisor to Evaluate Strategic Alternatives

    George Burdette, current Chief Financial Officer, appointed Chief Executive Officer Roth Capital Partners retained as financial advisor to evaluate strategic alternatives, including potential merger or sale Verde Clean Fuels, Inc. (NASDAQ:VGAS) ("Verde" or the "Company") announced today the appointment of George Burdette as Chief Executive Officer ("CEO") and engagement of Roth Capital Partners ("Roth") as financial advisor to assist the Company in evaluating strategic alternatives. These announcements are part of the Company's continued advancement of its previously announced restructuring and cost reduction initiatives. Mr. Burdette succeeds Ernie Miller who is stepping down from h

    3/20/26 6:13:00 PM ET
    $FSLR
    $VGAS
    Semiconductors
    Technology
    Major Chemicals
    Industrials

    ImmunityBio Announces Approval in Macau SAR, China for ANKTIVA® in BCG-Unresponsive NMIBC with CIS ± Papillary Tumors

    Macau SAR, China regulator grants approval for ANKTIVA® (nogapendekin alfa inbakicept-pmln) in patients with BCG-unresponsive NMIBC with CIS ± papillary tumors Authorization follows a reliance-based review referencing prior FDA and EMA decisions First ANKTIVA authorization in Asia, supporting ongoing global expansion across 34 countries and territories ImmunityBio, Inc. ((IBRX), today announced that the Pharmaceutical Administration Bureau (ISAF) of the Macau Special Administrative Region of the People's Republic of China has granted regulatory approval for ANKTIVA® (nogapendekin alfa inbakicept-pmln). The approval establishes ANKTIVA's initial presence in Asia and reflects the

    3/20/26 1:08:00 PM ET
    $IBRX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Holley Performance Brands Acquires HRX, Expanding Safety & Racing Portfolio

    NASHVILLE, Tenn., March 20, 2026 (GLOBE NEWSWIRE) -- Holley Performance Brands (NYSE:HLLY), a leader in automotive aftermarket performance solutions, today announced it has acquired HRX, an Italian motorsports racewear brand serving drivers and teams across karting and competitive racing categories. The terms of the transaction were not disclosed. HRX has established a presence across European racing circuits and select international markets, focusing on technical racewear, customization and customer relationships within the motorsports community. The acquisition adds complementary racewear capabilities to Holley's Safety & Racing portfolio and expands the company's presence in European

    3/20/26 8:30:00 AM ET
    $HLLY
    Auto Parts:O.E.M.
    Consumer Discretionary

    $AIRS
    $AKU
    $ARLO
    $ARRY
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    BTIG Research resumed coverage on ImmunityBio with a new price target

    BTIG Research resumed coverage of ImmunityBio with a rating of Buy and set a new price target of $13.00

    3/12/26 8:52:16 AM ET
    $IBRX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Northland Capital initiated coverage on Avita Medical with a new price target

    Northland Capital initiated coverage of Avita Medical with a rating of Outperform and set a new price target of $10.00

    3/5/26 8:30:26 AM ET
    $RCEL
    Medical/Dental Instruments
    Health Care

    First Solar downgraded by Deutsche Bank with a new price target

    Deutsche Bank downgraded First Solar from Buy to Hold and set a new price target of $245.00

    2/26/26 7:10:22 AM ET
    $FSLR
    Semiconductors
    Technology

    $AIRS
    $AKU
    $ARLO
    $ARRY
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SVP, Regulatory Affairs Bedoya-Toro Munera Maria E bought $1,270 worth of shares (1,000 units at $1.27), increasing direct ownership by 8,333% to 1,012 units (SEC Form 4)

    4 - Dermata Therapeutics, Inc. (0001853816) (Issuer)

    3/17/26 5:44:21 PM ET
    $DRMA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Financial Officer Mcgrath Kenneth J bought $66,030 worth of shares (22,021 units at $3.00), increasing direct ownership by 4% to 557,262 units (SEC Form 4)

    4 - ORASURE TECHNOLOGIES INC (0001116463) (Issuer)

    3/16/26 8:01:53 PM ET
    $OSUR
    Medical/Dental Instruments
    Health Care

    President & CEO Eglinton Manner Carrie bought $66,033 worth of shares (22,022 units at $3.00), increasing direct ownership by 1% to 2,158,574 units (SEC Form 4)

    4 - ORASURE TECHNOLOGIES INC (0001116463) (Issuer)

    3/16/26 8:01:38 PM ET
    $OSUR
    Medical/Dental Instruments
    Health Care

    $AIRS
    $AKU
    $ARLO
    $ARRY
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Tewksbury Ted L Iii

    4 - Ouster, Inc. (0001816581) (Issuer)

    3/23/26 4:05:18 PM ET
    $OUST
    Industrial Machinery/Components
    Industrials

    SEC Form 4 filed by Chernett Jorey

    4 - Airsculpt Technologies, Inc. (0001870940) (Issuer)

    3/23/26 9:33:39 AM ET
    $AIRS
    Medical/Nursing Services
    Health Care

    SEC Form 4 filed by Jashnani Yogesh

    4 - Airsculpt Technologies, Inc. (0001870940) (Issuer)

    3/20/26 8:11:37 PM ET
    $AIRS
    Medical/Nursing Services
    Health Care

    $AIRS
    $AKU
    $ARLO
    $ARRY
    SEC Filings

    View All

    SEC Form S-4 filed by IonQ Inc.

    S-4 - IonQ, Inc. (0001824920) (Filer)

    3/20/26 5:26:42 PM ET
    $IONQ
    EDP Services
    Technology

    SEC Form DEFA14A filed by Emergent BioSolutions Inc.

    DEFA14A - Emergent BioSolutions Inc. (0001367644) (Filer)

    3/20/26 4:52:32 PM ET
    $EBS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form DEF 14A filed by Emergent BioSolutions Inc.

    DEF 14A - Emergent BioSolutions Inc. (0001367644) (Filer)

    3/20/26 4:51:06 PM ET
    $EBS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AIRS
    $AKU
    $ARLO
    $ARRY
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for ZYNRELEF KIT issued to HERON THERAPS INC

    Submission status for HERON THERAPS INC's drug ZYNRELEF KIT (SUPPL-18) with active ingredient BUPIVACAINE; MELOXICAM has changed to 'Approval' on 11/21/2024. Application Category: NDA, Application Number: 211988, Application Classification: Labeling

    11/22/24 4:36:11 AM ET
    $HRTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for APONVIE issued to HERON THERAPS INC

    Submission status for HERON THERAPS INC's drug APONVIE (SUPPL-3) with active ingredient APREPITANT has changed to 'Approval' on 03/05/2024. Application Category: NDA, Application Number: 216457, Application Classification: Labeling

    3/11/24 4:38:31 AM ET
    $HRTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for CINVANTI issued to HERON THERAPS INC

    Submission status for HERON THERAPS INC's drug CINVANTI (SUPPL-15) with active ingredient APREPITANT has changed to 'Approval' on 03/05/2024. Application Category: NDA, Application Number: 209296, Application Classification: Labeling

    3/11/24 4:38:29 AM ET
    $HRTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AIRS
    $AKU
    $ARLO
    $ARRY
    Leadership Updates

    Live Leadership Updates

    View All

    Verde Clean Fuels, Inc. Announces New CEO and Engagement of Financial Advisor to Evaluate Strategic Alternatives

    George Burdette, current Chief Financial Officer, appointed Chief Executive Officer Roth Capital Partners retained as financial advisor to evaluate strategic alternatives, including potential merger or sale Verde Clean Fuels, Inc. (NASDAQ:VGAS) ("Verde" or the "Company") announced today the appointment of George Burdette as Chief Executive Officer ("CEO") and engagement of Roth Capital Partners ("Roth") as financial advisor to assist the Company in evaluating strategic alternatives. These announcements are part of the Company's continued advancement of its previously announced restructuring and cost reduction initiatives. Mr. Burdette succeeds Ernie Miller who is stepping down from h

    3/20/26 6:13:00 PM ET
    $FSLR
    $VGAS
    Semiconductors
    Technology
    Major Chemicals
    Industrials

    Altai Capital Management Issues Letter to OraSure Board Outlining Five-Pillar Case for Change in Response to Significant and Continued Underperformance

    Calls on Company to Reach a Fair Settlement that Appoints Altai Nominees Rishi Bajaj and John Bertrand to the Board Altai Capital Management, L.P. ("Altai"), one of the largest shareholders and the beneficial owners of approximately 5% of the outstanding common stock of OraSure Technologies, Inc. ("OraSure" or the "Company") (NASDAQ:OSUR), today announced that it has delivered a letter to the OraSure Board of Directors (the "Board") outlining a five-pillar case for why change is necessary to preserve and deliver value for its investors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260317768148/en/ In the letter, Altai calls

    3/17/26 9:15:00 AM ET
    $OSUR
    Medical/Dental Instruments
    Health Care

    The $17 Billion Solar Maintenance Market Just Got a New Player From the Defense Sector

    Issued on behalf of VisionWave Holdings, Inc. Companies mentioned in this article: VisionWave Holdings (NASDAQ:VWAV), First Solar (NASDAQ:FSLR), Enphase Energy (NASDAQ:ENPH), SunPower (NASDAQ:SPWR), SolarEdge Technologies (NASDAQ:SEDG) Key Takeaways: VisionWave Holdings (NASDAQ:VWAV) subsidiary SolarDrone has acquired a 51% controlling interest in Junko Solar, an Israeli solar panel maintenance and cleaning company, and appointed its founder Amos Cohen as SolarDrone CEO.The global solar panel operation and maintenance market is valued at $17 billion in 2026 and projected to reach nearly $60 billion by 2035, growing at a 13.3% CAGR[1].First Solar inaugurated a $1.1 billion AI-enabled manuf

    3/17/26 9:00:00 AM ET
    $ENPH
    $FSLR
    $SEDG
    Semiconductors
    Technology
    Computer Software: Prepackaged Software

    $AIRS
    $AKU
    $ARLO
    $ARRY
    Financials

    Live finance-specific insights

    View All

    Holley Performance Brands Acquires HRX, Expanding Safety & Racing Portfolio

    NASHVILLE, Tenn., March 20, 2026 (GLOBE NEWSWIRE) -- Holley Performance Brands (NYSE:HLLY), a leader in automotive aftermarket performance solutions, today announced it has acquired HRX, an Italian motorsports racewear brand serving drivers and teams across karting and competitive racing categories. The terms of the transaction were not disclosed. HRX has established a presence across European racing circuits and select international markets, focusing on technical racewear, customization and customer relationships within the motorsports community. The acquisition adds complementary racewear capabilities to Holley's Safety & Racing portfolio and expands the company's presence in European

    3/20/26 8:30:00 AM ET
    $HLLY
    Auto Parts:O.E.M.
    Consumer Discretionary

    IHS Holding Limited Reports Fourth Quarter and Full Year 2025 Financial Results

    SOLID FULL YEAR 2025 REVENUE GROWTH AND FREE CASH FLOW GENERATION IHS Holding Limited (NYSE:IHS) ("IHS Towers" or the "Company"), one of the largest independent owners, operators, and developers of shared communications infrastructure in the world by tower count, today reported financial results for the fourth quarter and full year ended December 31, 2025. CONSOLIDATED HIGHLIGHTS – FOURTH QUARTER AND FULL YEAR 2025 The table below sets forth the select financial results for the three months and twelve months ended December 31, 2025 and 2024:                           Full year ended December 31,

    3/16/26 9:55:00 AM ET
    $IHS
    Telecommunications Equipment
    Telecommunications

    P3 Health Partners Schedules Fourth Quarter and Full Year 2025 Earnings Release and Conference Call

    P3 Health Partners Inc. ("P3" or the "Company") (NASDAQ:PIII), a patient-centered and physician-led population health management company, today announced that the Company plans to release its financial results for fourth quarter and full year 2025 on Thursday, March 26, 2026. In connection with the release, management will host a conference call to discuss the financial results at 1:30pm PT/ 4:30pm ET the same day. Title & Webcast P3 Health Fourth Quarter and Full Year 2025 Earnings Conference Call Date & Time March 26, 2026, 4:30pm Eastern Time Conference Call Details Toll-Free 1-833-316-0546 International 1-412-317-0692 Ask to be joined into t

    3/13/26 8:05:00 AM ET
    $PIII
    Medical/Nursing Services
    Health Care

    $AIRS
    $AKU
    $ARLO
    $ARRY
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13D filed by First Solar Inc.

    SC 13D - FIRST SOLAR, INC. (0001274494) (Subject)

    12/10/24 1:11:10 PM ET
    $FSLR
    Semiconductors
    Technology

    SEC Form SC 13G filed by Cidara Therapeutics Inc.

    SC 13G - Cidara Therapeutics, Inc. (0001610618) (Subject)

    12/9/24 5:37:15 PM ET
    $CDTX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form SC 13G filed by VCI Global Limited

    SC 13G - VCI Global Ltd (0001930510) (Subject)

    12/6/24 6:01:22 AM ET
    $VCIG
    Diversified Commercial Services
    Consumer Discretionary